SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Aesthetic Medical International Holdings Group Ltd – ‘6-K’ for 11/30/19

On:  Tuesday, 11/26/19, at 8:54am ET   ·   For:  11/30/19   ·   Accession #:  1104659-19-67269   ·   File #:  1-39088

Previous ‘6-K’:  None   ·   Next:  ‘6-K’ on 3/6/20 for 3/31/20   ·   Latest:  ‘6-K’ on / for 3/8/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/26/19  Aesthetic Medical Int’l Hold… Ltd 6-K        11/30/19    2:664K                                   Toppan Merrill/FA

Current Report by a Foreign Issuer   —   Form 6-K   —   Rule 13a-16 / 15d-16
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 6-K         Current Report by a Foreign Issuer                  HTML     13K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML    386K 


‘6-K’   —   Current Report by a Foreign Issuer


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

Form 6-K

 


 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of November 2019

 

Commission File Number: 001-39088

 


 

Aesthetic Medical International Holdings Group Limited

 


 

1122 Nanshan Boulevard, Nanshan District

Shenzhen, Guangdong Province, 518052

People’s Republic of China

(Address of principal executive offices)

 


 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F x   Form 40-F o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o

 

 

 


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Aesthetic Medical International Holdings Group Limited

 

 

 

By:

/s/ Wu Guanhua

 

Name:

Wu Guanhua

 

Title:

Chief Financial Officer

 

Date: November 26, 2019

 

2


 

EXHIBIT INDEX

 

Exhibit No.

 

Description

 

 

 

99.1

 

Press Release — Aesthetic Medical International Reports Third Quarter 2019 Unaudited Financial Results

 

3



Dates Referenced Herein

This ‘6-K’ Filing    Date    Other Filings
For Period end:11/30/19None on these Dates
Filed on:11/26/19
 List all Filings 
Top
Filing Submission 0001104659-19-067269   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Mar. 29, 10:42:32.2am ET